Tian An Medicare Limited (COLRF)
OTCMKTS · Delayed Price · Currency is USD
0.0800
-0.0380 (-32.20%)
At close: May 19, 2025
Tian An Medicare Revenue
Tian An Medicare had revenue of 783.13M HKD in the half year ending June 30, 2025, with 2.91% growth. This brings the company's revenue in the last twelve months to 1.59B, down -2.49% year-over-year. In the year 2024, Tian An Medicare had annual revenue of 1.63B with 3.72% growth.
Revenue (ttm)
1.59B HKD
Revenue Growth
-2.49%
P/S Ratio
0.63
Revenue / Employee
589.76K HKD
Employees
2,694
Market Cap
128.46M USD
Revenue Chart
* This company reports financials in HKD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.63B | 58.38M | 3.72% |
| Dec 31, 2023 | 1.57B | 130.96M | 9.11% |
| Dec 31, 2022 | 1.44B | -25.63M | -1.75% |
| Dec 31, 2021 | 1.46B | 269.35M | 22.56% |
| Dec 31, 2020 | 1.19B | -33.42M | -2.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veltex | 70.13M |
| Selectis Health | 42.17M |
| Mid-Atlantic Home Health Network | 27.00M |
| Cardiff Lexington | 11.88M |
| Stem Cell Authority | 3.33M |
| Xcelerate | 2.70M |
| HealthLynked | 2.37M |